» Articles » PMID: 35273814

Overcoming Barriers to Diabetes Technology in Youth with Type 1 Diabetes and Public Insurance: Cases and Call to Action

Overview
Publisher Wiley
Specialty Endocrinology
Date 2022 Mar 11
PMID 35273814
Authors
Affiliations
Soon will be listed here.
Abstract

Advancements in diabetes technology such as continuous glucose monitoring (CGM), insulin pumps, and automated insulin delivery provide opportunities to improve glycemic control for youth with type 1 diabetes (T1D). However, diabetes technology use is lower in youth on public insurance, and this technology use gap is widening in the US. There is a significant need to develop effective interventions and policies to promote equitable care. The dual purpose of this case series is as follows: (1) describe success stories of the CGM Time in Range Program (CGM TIPs), which removed barriers for initiating CGM and provided asynchronous remote glucose monitoring for youth on public insurance, and (2) advocate for improving CGM coverage by public insurance. We describe a series of six youths with T1D and public insurance who obtained and sustained use of CGM with assistance from the program. Three youths had improved engagement with the care team while on CGM and the remote monitoring protocol, and three youths were able to leverage sustained CGM wear to obtain insurance coverage for automated insulin delivery systems. CGM TIPs helped these youths achieve lower hemoglobin A1c and improved time in range (TIR). Despite the successes, expansion of CGM TIPs is limited by stringent barriers for CGM approval and difficult postapproval patient workflows to receive shipments. These cases highlight the potential for combining diabetes technology and asynchronous remote monitoring to support continued use and provide education to improve glycemic control for youth with T1D on public insurance and the need to reduce barriers for obtaining CGM coverage by public insurance.

Citing Articles

Addressing Disparities Using Continuous Glucose Monitors and Remote Patient Monitoring for Youth With Type 1 Diabetes.

Lee M, Ritter V, Shaw B, Ferstad J, Johari R, Scheinker D J Diabetes Sci Technol. 2024; 19322968241305612.

PMID: 39711469 PMC: 11664559. DOI: 10.1177/19322968241305612.


Disparities in Diabetes Technology Uptake in Youth and Young Adults With Type 1 Diabetes: A Global Perspective.

Conway R, Snell-Bergeon J, Honda-Kohmo K, Peddi A, Isa S, Sulong S J Endocr Soc. 2024; 9(1):bvae210.

PMID: 39703363 PMC: 11655873. DOI: 10.1210/jendso/bvae210.


Barriers to Type 1 Diabetes Adherence in Adolescents.

Azar S, Maroun Abou Jaoude N, Kedzia A, Niechcial E J Clin Med. 2024; 13(19).

PMID: 39407728 PMC: 11477045. DOI: 10.3390/jcm13195669.


Unveiling the interplay between rational, psychological and functional factors in continuous glucose monitoring early adoption: Novel evidence from the Dexcom ONE case in Italy.

Zoccarato F, Manzoni M, Minotti D, Lettieri E, Boaretto A BMC Health Serv Res. 2024; 24(1):747.

PMID: 38890619 PMC: 11186290. DOI: 10.1186/s12913-024-11195-6.


The impact of socioeconomic factors, social determinants, and ethnicity on the utilization of glucose sensor technology among persons with diabetes mellitus: a narrative review.

Been R, Lameijer A, Gans R, van Beek A, Kingsnorth A, Choudhary P Ther Adv Endocrinol Metab. 2024; 15:20420188241236289.

PMID: 38476216 PMC: 10929059. DOI: 10.1177/20420188241236289.


References
1.
Dai X, Luo Z, Zhai L, Zhao W, Huang F . Artificial Pancreas as an Effective and Safe Alternative in Patients with Type 1 Diabetes Mellitus: A Systematic Review and Meta-Analysis. Diabetes Ther. 2018; 9(3):1269-1277. PMC: 5984939. DOI: 10.1007/s13300-018-0436-y. View

2.
Walker A, Hood K, Gurka M, Filipp S, Anez-Zabala C, Cuttriss N . Barriers to Technology Use and Endocrinology Care for Underserved Communities With Type 1 Diabetes. Diabetes Care. 2021; 44(7):1480-1490. PMC: 8323174. DOI: 10.2337/dc20-2753. View

3.
Yeh H, Brown T, Maruthur N, Ranasinghe P, Berger Z, Suh Y . Comparative effectiveness and safety of methods of insulin delivery and glucose monitoring for diabetes mellitus: a systematic review and meta-analysis. Ann Intern Med. 2012; 157(5):336-47. DOI: 10.7326/0003-4819-157-5-201209040-00508. View

4.
Bekiari E, Kitsios K, Thabit H, Tauschmann M, Athanasiadou E, Karagiannis T . Artificial pancreas treatment for outpatients with type 1 diabetes: systematic review and meta-analysis. BMJ. 2018; 361:k1310. PMC: 5902803. DOI: 10.1136/bmj.k1310. View

5.
Lyles C, Wachter R, Sarkar U . Focusing on Digital Health Equity. JAMA. 2021; 326(18):1795-1796. DOI: 10.1001/jama.2021.18459. View